Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2170137-61-6 (free base) |
|---|---|
| Purity | ≥98% |
| Formula | C16H25N5 |
| Formula Wt. | 287.41 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
| Synonym | KB0742, NSC-834161, NSC834161 |
| Appearance | Yellow to brown crystal |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Fluoroquinolone, S-(-) isomer of ofloxacin; top...
Endogenous peptide hormone; GnRH agonist.
NO donor.
Mycotoxin contaminant in food and feed.
Fungistatic
EGFR inhibitor.
Selective cannabinoid receptor 2 (CB2) inverse ...
Isoflavone, phytoestrogen found in soy
ALK5 (activin-like) antagonist.
Piperadine phenothiazine; FIASMA, D1-5, histami...
Camptothecin analog; topoisomerase I inhibitor,...
Steroid; glucocorticoid agonist.
B-Raf inhibitor.
Pyridopyrimidinone; PI3K and mTOR inhibitor.
FGFR inhibitor.
Triterpene saponin found in Panax; Kv7.1 K+ cha...
Synthetic ITC.
S-enantiomer of citalopram; SERT inhibitor.
β1/2-adrenergic antagonist.
Triterpene; potential tyrosinase inhibitor.